Supporting the analyses described above, CREMA revealed several transcription factors showing the same response to NASH and lipotoxicity, such as CEBPZ, ATF3 and NFIB (Table S5). This evidence concerns the gene NFIB and metabolic dysfunction-associated steatohepatitis.